UROLOGY, cilt.82, sa.3, 2013 (SCI-Expanded, Scopus)
OBJECTIVE To evaluate the effect of the tyrosine kinase inhibitor imatinib mesylate (Gleevec) on human corpus cavernosum (HCC) smooth muscle tone.